GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lanzhou Foci Pharmaceutical Co Ltd (SZSE:002644) » Definitions » Debt-to-Equity

Lanzhou Foci Pharmaceutical Co (SZSE:002644) Debt-to-Equity : 0.02 (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Lanzhou Foci Pharmaceutical Co Debt-to-Equity?

Lanzhou Foci Pharmaceutical Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥24.9 Mil. Lanzhou Foci Pharmaceutical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥1.4 Mil. Lanzhou Foci Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Sep. 2024 was ¥1,769.2 Mil. Lanzhou Foci Pharmaceutical Co's debt to equity for the quarter that ended in Sep. 2024 was 0.01.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Lanzhou Foci Pharmaceutical Co's Debt-to-Equity or its related term are showing as below:

SZSE:002644' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01   Med: 0.02   Max: 0.09
Current: 0.02

During the past 13 years, the highest Debt-to-Equity Ratio of Lanzhou Foci Pharmaceutical Co was 0.09. The lowest was 0.01. And the median was 0.02.

SZSE:002644's Debt-to-Equity is ranked better than
92.62% of 827 companies
in the Drug Manufacturers industry
Industry Median: 0.28 vs SZSE:002644: 0.02

Lanzhou Foci Pharmaceutical Co Debt-to-Equity Historical Data

The historical data trend for Lanzhou Foci Pharmaceutical Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lanzhou Foci Pharmaceutical Co Debt-to-Equity Chart

Lanzhou Foci Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.02 0.01 0.01 0.02

Lanzhou Foci Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.02 0.01 0.02

Competitive Comparison of Lanzhou Foci Pharmaceutical Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Lanzhou Foci Pharmaceutical Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lanzhou Foci Pharmaceutical Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lanzhou Foci Pharmaceutical Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Lanzhou Foci Pharmaceutical Co's Debt-to-Equity falls into.



Lanzhou Foci Pharmaceutical Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Lanzhou Foci Pharmaceutical Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Lanzhou Foci Pharmaceutical Co's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lanzhou Foci Pharmaceutical Co  (SZSE:002644) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Lanzhou Foci Pharmaceutical Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Lanzhou Foci Pharmaceutical Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Lanzhou Foci Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
68 Foci Street ChangGuan Region, Lanzhou, CHN, 730046
Lanzhou Foci Pharmaceutical Co Ltd is a pharmaceutical company based in China. The company is engaged in the production and sales of Chinese traditional medicine. In addition to manufacturing, the company also conducts research to develop new herbal drugs. Its product portfolio consists of concentrated pills, granules, hard capsules, concentrated decoctions and medicinal wine. The products of the company are exported to more than 27 countries including the United States, Canada, Japan, Australian, Russia, Ukraine, among others.
Executives
Sun Yu Directors, executives
Su Wen Bo Supervisors
An Wen Ting Securities Affairs Representative

Lanzhou Foci Pharmaceutical Co Headlines

No Headlines